Brainstorm Cell Therapeutics

$5.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+0.91%) As of 3:13 PM UTC today

Why Robinhood?

You can buy or sell BCLI and other stocks, options, and ETFs commission-free!

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ. The listed name for BCLI is Brainstorm Cell Therapeutics Inc. Common Stock.

CEO
Chaim Lebovits
Employees
32
Headquarters
New York, New York
Founded
2000
Market Cap
177.09M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.84M
High Today
$5.64
Low Today
$5.38
Open Price
$5.48
Volume
156.54K
52 Week High
$17.95
52 Week Low
$3.63

Collections

BCLI Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 16, Pre-Market

You May Also Like